CIK 0001178253 · Non-accelerated filer<br>Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 562181648
- Phone
- 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-15 | Sukenick Scott General Counsel | Shares withheld for taxes | −783 | $9.80 | $8K | 9,912 |
| 2020-02-15 | Francois Eric Chief Financial Officer | Shares withheld for taxes | −979 | $9.80 | $10K | 14,412 |
| 2020-02-15 | Angulo Gonzalez David Chief Medical Officer | Shares withheld for taxes | −1,175 | $9.80 | $12K | 26,303 |
| 2020-01-31 | Sukenick Scott General Counsel | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-01-31 | Francois Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 |
Page 9 of 9 · 165 trades